Loading company…
RenBio develops DNA therapeutics using its Make Your Own technology platform.
Founded in 2016 and based in New York, RenBio develops therapeutic products using its Make Your Own platform, which delivers instructions for muscle cells to produce disease-fighting therapeutics. Its work focuses on antibody and protein treatments, including for infectious diseases. In October 2022, it received a USD 1.00 mn grant from the Defense Advanced Research Projects Agency.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in